Tert-butyl 4-[4-[6-amino-5-(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate;tert-butyl 4-[4-[6-amino-5-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate
C49H55N17O6 — CID 174231478
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[4-[6-amino-5-(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate;tert-butyl 4-[4-[6-amino-5-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate
Tert-butyl 4-[4-[6-amino-5-(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate;tert-butyl 4-[4-[6-amino-5-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate (PubChem CID 174231478) has the molecular formula C49H55N17O6 and a molecular weight of 978.09 g/mol. Its IUPAC name is tert-butyl 4-[4-[6-amino-5-(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate;tert-butyl 4-[4-[6-amino-5-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl 4-[4-[6-amino-5-(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate;tert-butyl 4-[4-[6-amino-5-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate |
|---|---|
| PubChem CID | 174231478 |
| Molecular Formula | C49H55N17O6 |
| Molecular Weight | 978.09 g/mol |
| Exact Mass | 977.45 |
| IUPAC Name | tert-butyl 4-[4-[6-amino-5-(5-pyrazin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate;tert-butyl 4-[4-[6-amino-5-(5-pyridin-2-yl-1,3,4-oxadiazol-2-yl)-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1CCC(n2cc(-c3cnc(N)c(-c4nnc(-c5ccccn5)o4)c3)cn2)CC1.CC(C)(C)OC(=O)N1CCC(n2cc(-c3cnc(N)c(-c4nnc(-c5cnccn5)o4)c3)cn2)CC1 |
| InChI | InChI=1S/C25H28N8O3.C24H27N9O3/c1-25(2,3)36-24(34)32-10-7-18(8-11-32)33-15-17(14-29-33)16-12-19(21(26)28-13-16)22-30-31-23(35-22)20-6-4-5-9-27-20;1-24(2,3)36-23(34)32-8-4-17(5-9-32)33-14-16(12-29-33)15-10-18(20(25)28-11-15)21-30-31-22(35-21)19-13-26-6-7-27-19/h4-6,9,12-15,18H,7-8,10-11H2,1-3H3,(H2,26,28);6-7,10-14,17H,4-5,8-9H2,1-3H3,(H2,25,28) |
| InChIKey | OTKOTCYBVZNFBM-UHFFFAOYSA-N |
| XLogP | 7.82 |
| TPSA | 289.05 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 72 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 978.09 |
| LogP ≤ 5 | 7.82 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 21 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 174231478 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.